Zusammenfassung
Die Organisation der Arzneimitteltherapie von Pflegeheimbewohnern ist von besonderer Bedeutung, um unerwünschte Arzneimittelereignisse zu vermeiden. Drei Viertel der Pflegeheimbewohner nehmen fünf oder mehr Dauer- und mindestens ein Bedarfsmedikament ein. Jeder fünfte Pflegeheimbewohner erhält eine Dauermedikation, die bei vorliegender Nierenfunktion nicht adäquat dosiert ist. Die Ergebnisse verdeutlichen den besonderen Stellenwert der Arzneimitteltherapie-sicherheit bei Pflegeheimbewohnern.
Abstract
An optimal organisation of a nursing home residents’ whole drug regime is crucial to avoid adverse drug effects. Three of four nursing home residents are treated with five or more long-term medications and received at least one as-needed drug. Nearly one fifth is regularly taking at least one medication that is contraindicated or incorrectly dosed in the light of renal insufficiency. The results demonstrate the importance of drug safety in nursing home residents.
Autorenerklärung
Autorenbeteiligung: Alle Autoren tragen Verantwortung für den gesamten Inhalt dieses Artikels und haben der Einreichung des Manuskripts zugestimmt. Finanzierung: Die Studie wurde finanziell durch die KfH-Stiftung Präventivmedizin unterstützt. Die KfH-Stiftung Präventivmedizin war nicht an der wissenschaftlichen Auswertung der Daten beteiligt und hatte keinen Einfluss auf die Erstellung des Manuskripts und die Entscheidung der Einreichung zur Publikation. Interessenkonflikt: Die Autoren erklären, dass kein wirtschaftlicher oder persönlicher Interessenkonflikt vorliegt. Ethisches Statement: Für die Forschungsarbeit wurden weder von Menschen noch von Tieren Primärdaten erhoben.
Author Declaration
Author contributions: All authors have accepted responsibility for the entire content of this submitted manuscript and approved submission. Funding: This work was supported by the KfH-Stiftung Präventivmedizin. The non-profit KfH-Stiftung Präventivmedizin was not involved in the scientific analyses and had no influence on the manuscript and the publication process. Conflict of interest: Authors state no conflict of interest. Ethical statement: Primary data for human nor for animals were not collected for this research work.
Literatur
1. Rothgang H, Kalwitzki T, Müller R, Runte R, Unger R. BARMER GEK Pflegereport 2015. St. Augustin: Asgard, 2015.Search in Google Scholar
2. Reason B, Terner M, Moses McKeag A, Tipper B, Webster G. The impact of polypharmacy on the health of Canadian seniors. Fam Pract 2012;29:427–32.10.1093/fampra/cmr124Search in Google Scholar PubMed
3. Hartmann B, Czock D, Keller F. Drug therapy in patients with chronic renal failure. Dtsch Ärztebl Int 2010;107:647–56.10.3238/arztebl.2010.0647Search in Google Scholar PubMed PubMed Central
4. Aguilar EA, Ashraf H, Frontini M, Ruiz M, Reske TM, Cefalu C. An analysis of chronic kidney disease risk factors in a Louisiana nursing home population: a cross-sectional study. J La State Med Soc 2013;165:260–3, 265–7.Search in Google Scholar
5. Chan TC, Yap DY, Shea YF, Luk KH, Chan HW, Chu LW. Prevalence and associated comorbidities of moderate to severe chronic renal impairment in Chinese nursing home older adults. J Am Med Dir Assoc 2012;13:630–3.10.1016/j.jamda.2012.05.007Search in Google Scholar PubMed
6. Joseph J, Koka M, Aronow WS. Prevalence of moderate and severe renal insufficiency in older persons with hypertension, diabetes mellitus, coronary artery disease, peripheral arterial disease, ischemic stroke, or congestive heart failure in an academic nursing home. J Am Med Dir Assoc 2008;9:257–9.10.1016/j.jamda.2008.01.002Search in Google Scholar PubMed
7. Schnelle J, Osterweil D, Globe D, Sciarra A, Audhya P, Barlev A. Chronic kidney disease, anemia, and the association between chronic kidney disease-related anemia and activities of daily living in older nursing home residents. J Am Med Dir Assoc 2009;10:120–6.10.1016/j.jamda.2008.08.012Search in Google Scholar PubMed
8. Garg AX, Papaioannou A, Ferko N, Campbell G, Clarke JA, Ray JG. Estimating the prevalence of renal insufficiency in seniors requiring long-term care. Kidney Int 2004;65:649–53.10.1111/j.1523-1755.2004.00412.xSearch in Google Scholar PubMed
9. Robinson B, Artz AS, Culleton B, Critchlow C, Sciarra A, Audhya P. Prevalence of anemia in the nursing home: contribution of chronic kidney disease. J Am Geriatr Soc 2007;55:1566–70.10.1111/j.1532-5415.2007.01389.xSearch in Google Scholar PubMed
10. Hanlon JT, Wang X, Handler SM, Weisbord S, Pugh MJ, Semla T, et al. Potentially inappropriate prescribing of primarily renally cleared medications for older Veterans Affairs nursing home patients. J Am Med Dir Assoc 2011;12:377–83.10.1016/j.jamda.2010.04.008Search in Google Scholar PubMed PubMed Central
11. Rahimi AR, Kennedy K, Thomason M, Crumley J, Bugg A, Peacock E. Improper renal dosing in long-term care facilities. South Med J 2008;101:802–5.10.1097/SMJ.0b013e31817f1f71Search in Google Scholar PubMed
12. Papaioannou A, Clarke JA, Campbell G, Bédard M. Assessment of adherence to renal dosing guidelines in long-term care facilities. J Am Geriatr Soc 2000;48:1470–3.10.1111/j.1532-5415.2000.tb02639.xSearch in Google Scholar PubMed
13. Dörks M, Allers K, Schmiemann G, Herget-Rosenthal S, Hoffmann F. Inappropriate medication in non-hospitalized patients with renal insufficiency: a systematic review. J Am Geriatr Soc 2017;65:853–62.10.1111/jgs.14809Search in Google Scholar PubMed
14. Hoffmann F, Boeschen D, Dörks M, Herget-Rosenthal S, Petersen J, Schmiemann G. Renal insufficiency and medication in nursing home residents – a cross-sectional study (IMREN). Dtsch Ärztebl Int 2016;113:92–8.Search in Google Scholar
15. Dörks M, Herget-Rosenthal S, Schmiemann G, Hoffmann F. Polypharmacy and renal failure in nursing home residents: results of the inappropriate medication in patients with renal insufficiency in nursing homes (IMREN) study. Drugs Aging 2015;33:45–51.10.1007/s40266-015-0333-2Search in Google Scholar PubMed
16. Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract 2007;24:14–9.10.1093/fampra/cml067Search in Google Scholar PubMed
17. Mckillop G, Joy J. Patients’ experience and perceptions of polypharmacy in chronic kidney disease and its impact on adherent behaviour. J Ren Care 2013;39:200–7.10.1111/j.1755-6686.2013.12037.xSearch in Google Scholar PubMed
18. Fincke BG, Snyder K, Cantillon C, Gaehde S, Standring P, Fiore L, et al. Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database. Pharmacoepidemiol Drug Saf 2005;14:121–8.10.1002/pds.966Search in Google Scholar PubMed
19. Grimmsmann T, Himmel W. Polypharmacy in primary care practices: an analysis using a large health insurance database. Pharmacoepidemiol Drug Saf 2009;18:1206–13.10.1002/pds.1841Search in Google Scholar PubMed
20. Beloosesky Y, Nenaydenko O, Gross Nevo RF, Adunsky A, Weiss A. Rates, variability, and associated factors of polypharmacy in nursing home patients. Clin Interv Aging 2013;8:1585–90.10.2147/CIA.S52698Search in Google Scholar PubMed PubMed Central
21. Hoffmann F, Schmiemann G, Dörks M. [Assessment of polypharmacy: a question of definition and underlying data]. Zeitschrift für Evidenz, Fortbildung und Qual im Gesundheitswes 2016;113:27–35.10.1016/j.zefq.2016.03.004Search in Google Scholar PubMed
22. Dörks M, Schmiemann G, Hoffmann F. Pro re nata (as needed) medication in nursing homes: the longer you stay, the more you get? Eur J Clin Pharmacol 2016;72:995–1001.10.1007/s00228-016-2059-4Search in Google Scholar PubMed
23. Schmiemann G, Dehlfing A, Pulst A, Hoffmann F. Arzneimitteltherapiesicherheit bei Pflegeheimbewohnern mit eingeschränkter Nierenfunktion – Ergebnisse einer qualitativen Studie. Z Evid Fortbild Qual Gesundhwes 2017;121:14–20.10.1016/j.zefq.2017.02.003Search in Google Scholar PubMed
©2017 Walter de Gruyter GmbH, Berlin/Boston
